Minnesota medical device maker Conventus Orthopaedics is swapping some executives, naming a new chief executive officer and new chief commercial officer in one fell swoop.
The orthopedics company appointed as its new CEO Paul Buckman, who brought with him years of medtech experience at companies including Boston Scientific and St. Jude Medical. Buckman also co-founded ev3, which Covidien acquired in 2010 for $2.6 billion. Buckman has also served on Conventus’ board of directors since 2009.
Conventus also appointed David Blue its new chief commercial officer, touting his past stints at companies including Zimmer and DePuy.
The new hires were tasked with guiding the company "into commercial operations and market growth." Conventus landed FDA clearance earlier this year for its DRS orthopedic implant, designed to treat patients with distal radial fractures.
Pentax Medical appoints new global pres
Tokyo-based Hoya Group announced that its Pentax Medical endoscopy devices business has a new global president, Ganesh Ramaswamy. Ramaswamy was promoted from within, having joined the company in 2011 and climbing the ranks to senior vice president of global technology & quality before landing his new title.
LED Medical gets a new CEO
LED Medical Diagnostics (TSX:LMD, OTCQX:LEDIF) appointed Dr. David Gane its new chief, effective October 10. Gane is taking over for LED founder and president Peter Whitehead, who plans to transition to R&D and special projects.
CasMed names a new commercial chief
CasMed Medical Systems (NSDQ:CASM) announced the appointment of Brian Wagner as its new chief commercial officer, nabbing him from his chief marketing position at Philips Healthcare’s (NYSE:PHG) imaging division.
Escalon CEO steps down
Pennsylvania-based Escalon Medical (NSDQ:ESMC) announced the retirement of chairman & CEO Richard DePiano, who ceded control of daily operations late last month, remaining executive chairman of the board of directors and handing CEO duties to his son, Richard DePiano Jr.